These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 6381210)

  • 1. [Immune response to a histocompatible murine lymphoma. Synergism with chemotherapy].
    Scaringi L; Tissi L; Cassone A; Boccanera M; Marconi P
    G Ital Chemioter; 1984; 31(1-2):81-90. PubMed ID: 6381210
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunostimulation with inactivated Candida albicans and chemotherapy in murine lymphoma].
    Tissi L; Scaringi L; Cassone A; D'Errico P; Marconi P
    G Ital Chemioter; 1984; 31(1-2):91-100. PubMed ID: 6381211
    [No Abstract]   [Full Text] [Related]  

  • 3. Combined effects of chemotherapy and host antitumor response in a murine histocompatible lymphoma model.
    Marconi P; Scaringi L; Tissi L; Puccetti P; Cassone A
    Int J Immunopharmacol; 1984; 6(3):217-22. PubMed ID: 6378809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Further study of immunopotentiation in experimental antiblastic therapy by inactivated yeasts and glucan].
    Delfina Pesce C; Boccanera M; Marconi P; Bistoni F; Cenci E; Tissi L; Cassone A
    Ann Ist Super Sanita; 1982; 18(3):509-12. PubMed ID: 7187836
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of BCG as an immunoadjuvant in combination with antitumor agents in virus-induced leukemia].
    Sbaraglia G; Cenci E; Vecchiarelli A; Perito S
    Boll Soc Ital Biol Sper; 1980 Oct; 56(19):1969-75. PubMed ID: 7459108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined effects of BCG or Candida albicans (CA) with antitumor agents against a virus-induced lymphoma in mice.
    Bistoni F; Marconi P; Pitzurra M; Frati L; Spreafico F; Goldin A; Bonmassar E
    Eur J Cancer (1965); 1979 Nov; 15(11):1305-14. PubMed ID: 393515
    [No Abstract]   [Full Text] [Related]  

  • 7. CD4+ subset expression in murine candidiasis. Th responses correlate directly with genetically determined susceptibility or vaccine-induced resistance.
    Romani L; Mencacci A; Cenci E; Spaccapelo R; Mosci P; Puccetti P; Bistoni F
    J Immunol; 1993 Feb; 150(3):925-31. PubMed ID: 8093707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro studies of the interaction of murine phagocytic cells with Candida albicans.
    Morrison RP; Cutler JE
    J Reticuloendothel Soc; 1981 Jan; 29(1):23-34. PubMed ID: 7009855
    [No Abstract]   [Full Text] [Related]  

  • 9. Candida albicans mannan extract-protein conjugates induce a protective immune response against experimental candidiasis.
    Han Y; Ulrich MA; Cutler JE
    J Infect Dis; 1999 Jun; 179(6):1477-84. PubMed ID: 10228070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with antifungal vaccines.
    Beemer AM; Kuttin ES; Pinto M
    Contrib Microbiol Immunol; 1977; 4():136-46. PubMed ID: 342190
    [No Abstract]   [Full Text] [Related]  

  • 11. Testing and treatment with Candida albicans.
    Hosen H
    Ann Allergy; 1988 Nov; 61(5):405. PubMed ID: 3056126
    [No Abstract]   [Full Text] [Related]  

  • 12. Sleep and temperature responses of inbred mice with Candida albicans-induced pyelonephritis.
    Toth LA; Hughes LF
    Comp Med; 2006 Aug; 56(4):252-61. PubMed ID: 16941952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune responses to weakly immunogenic virally induced tumors. VI. Comparison of the immune response of the hybrid to the immune responses of the parents reveals "hybrid responsiveness" effect.
    Devens B; Naor D
    J Immunol; 1980 Sep; 125(3):988-94. PubMed ID: 6447725
    [No Abstract]   [Full Text] [Related]  

  • 14. Lymphokine-activated killer (LAK)-like cells induced in mice after repeated intraperitoneal injections of inactivated Candida albicans.
    Scaringi L; Rosati M; Bistoni F; Cassone A; Marconi P
    J Chemother; 1989 Jul; 1(4 Suppl):446-8. PubMed ID: 16312479
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunoproteomic analysis of the protective response obtained from vaccination with Candida albicans ecm33 cell wall mutant in mice.
    Martínez-López R; Nombela C; Diez-Orejas R; Monteoliva L; Gil C
    Proteomics; 2008 Jul; 8(13):2651-64. PubMed ID: 18546157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local and systemic immune response to inactivated Candida albicans in mice.
    Scaringi L; Rosati E; Cornacchione P; Fettucciari K; Sabatini R; Biondi R; Mezzasoma L; Valiani M; D'Errico P; Marconi P
    Nat Immun; 1995 Sep; 14(5-6):234-49. PubMed ID: 8933818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathological features of murine systemic vasculitis caused by Candida albicans extract--an animal model of Kawasaki disease.
    Takahashi K; Oharaseki T; Wakayama M; Yokouchi Y; Naoe S; Murata H
    Inflamm Res; 2004 Feb; 53(2):72-7. PubMed ID: 15021972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine model of Kawasaki disease induced by mannoprotein-beta-glucan complex, CAWS, obtained from Candida albicans.
    Ohno N
    Jpn J Infect Dis; 2004 Oct; 57(5):S9-10. PubMed ID: 15507772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Candida albicans cell wall glucan as adjuvant for induction of autoimmune arthritis in mice.
    Hida S; Miura NN; Adachi Y; Ohno N
    J Autoimmun; 2005 Sep; 25(2):93-101. PubMed ID: 16242302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility and resistance to Moloney murine leukemia virus-induced promonocytic leukemia.
    Nazarov V; Hilbert D; Wolff L
    Virology; 1994 Dec; 205(2):479-85. PubMed ID: 7975249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.